Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05922475 · ClinicalTrials.gov registry record · NA

Efficacy of Pre-sleep or Post-exercise Protein During 12 Weeks of Resistance Exercise Training

A NA study of Aging, sponsored by Florida State University.

Completed
Registry status
NA
Development phase
32
Enrollment target
1
Study location

NCT05922475: Completed NA study of Aging, sponsored by Florida State University.

NCT05922475 is a NA study of Aging that has completed, run by Florida State University. The registered enrollment target is 32 participants, below the 2,195-participant average among 262 other Aging trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05922475, a NA study of Aging, has completed, sponsored by Florida State University.

COMPLETED
Registry status
NA
Development phase
32 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to compare the effects of protein consumption before sleep or immediately after exercise during 12 weeks of resistance exercise training in older adults. The main questions it aims to answer are: Are there differences in muscle growth or strength during 12 weeks of resistance training when 40 grams of protein is consumed either before sleep or immediately after exercise? Are there differences in cognitive performance during 12 weeks of resistance training when 40 grams of protein is consumed either before sleep or immediately after exercise? This study is a randomized double-blind placebo-controlled study. Participants will be randomly allocated into 1 of 3 groups. All three groups will perform the same 12-week resistance exercise training program two times per week and consume 40 g of protein: 1) Immediately post-exercise, 2) 30 minutes prior to sleep, or 3) no supplemental protein (control). Test of muscle growth and strength, and cognitive performance will be measure before, during, and after the exercise training program. Researchers will compare the 3 conditions to determine if consume protein after exercise or before sleep during 12 weeks of resistance exercise training affects muscle growth and strength, and cognitive performance.

Primary Outcome

Change in muscle thickness of the quadriceps muscles in centimeters from week 0 (baseline) to week 6 (midpoint) to week 12 (end of study).

Conditions Studied

Interventions

  • OTHER Placebo
  • DIETARY_SUPPLEMENT Protein

Study Locations (1)

Florida

  • Florida State University - Tallahassee

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2017-09-27
Est. Completion 2019-05-03
Phase NA
Florida State University

219 total trials

What the finished NCT05922475 record still lists

NCT05922475 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 2,195-participant average among 262 other Aging trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Aging appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT05922475 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT05922475 about?

NCT05922475 is a clinical study titled "Efficacy of Pre-sleep or Post-exercise Protein During 12 Weeks of Resistance Exercise Training". The goal of this clinical trial is to compare the effects of protein consumption before sleep or immediately after exercise during 12 weeks of resistance exercise training in older adults. The main questions it aims to answer are: Are there differences in muscle growth or strength during 12 weeks o...

What is the current status of trial NCT05922475?

This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2017-09-27. Estimated completion is 2019-05-03.

What conditions does trial NCT05922475 study?

This clinical trial studies the following conditions: Aging.

What interventions are being tested in trial NCT05922475?

The interventions under investigation include: Placebo (OTHER), Protein (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT05922475?

This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05922475 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aging

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05922475's enrollment target sits among peer trials

32 188th of 262 higher than 72 of 262 other Aging trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Aging trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02445781 · 32 participants · Early Phase 1

    Differing Levels of Hypoglycemia

  • NCT02792270 · 32 participants · NA

    Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT

  • NCT03068910 · 32 participants · Early Phase 1

    Hyperandrogenemia and Altered Day-night LH Pulse Patterns

  • NCT03208868 · 32 participants · NA

    Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05922475, the US trial registry maintained by the National Library of Medicine. NCT05922475 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.